Intraosseous Morphine in Primary TKA
Intraosseous Morphine Administration During Primary Total Knee Arthroplasty: A Randomized Clinical Trial
Sponsor: The Methodist Hospital Research Institute
Listed as NCT04388111, this PHASE4 trial focuses on Arthritis Knee and Knee Disease and remains completed. Sponsored by The Methodist Hospital Research Institute, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
▶ Show 1 earlier version
-
Jun 2020 — Jan 2021 [monthly]
Recruiting PHASE4
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Methodist Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .